Gordon, L I, Kaplan, J B, Popat, R, Burris 3rd, H A, Ferrari, S, Madan, S, Patel, M R, Gritti, G, El-Sharkawi, D, Chau, I, Radford, J, Perez de Oteyza, J, Zinzani, P L, Iyer, S, Townsend, W, Karmali, R, Miao, H, Proscurshim, I, Wang, S, Wu, Y, Stumpo, K, Shou, Y, Carpio, C & Bosch, F 2020, ' Phase I Study of TAK-659, an Investigational, Dual SYK/FLT3 Inhibitor, in Patients with B-Cell Lymphoma ', Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 26, no. 14, pp. 3546-3556 . https://doi.org/10.1158/1078-0432.CCR-19-3239